<SEC-DOCUMENT>0001104659-11-021605.txt : 20110421
<SEC-HEADER>0001104659-11-021605.hdr.sgml : 20110421
<ACCEPTANCE-DATETIME>20110421132909
ACCESSION NUMBER:		0001104659-11-021605
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110421
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110421
DATE AS OF CHANGE:		20110421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		11772954

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a11-10719_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C.&nbsp; 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (date of earliest event reported):&nbsp;<b> April&nbsp;21, 2011</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">Merit Medical Systems,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Utah</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">0-18592</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">87-0447695</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other jurisdiction of</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">incorporation or organization)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1600 West Merit Parkway</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">South Jordan, Utah</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">84095</font></b></p>    </td>   </tr>
<tr>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.94%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.14%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="48%" valign="top" style="padding:0in 0in 0in 0in;width:48.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip Code)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(801) 253-1600</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">N/A</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former address, if changed since last report)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C900817\11-10719-1\task4630157\10719-1-ba.htm',USER='C900817',CD='Apr 21 21:37 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Item 8.01.&#160;&#160;&#160; <u>Other Events</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On April&nbsp;21, 2011, Merit Medical Systems,&nbsp;Inc. (the &#147;Company&#148;) issued a press release announcing that its Board of Directors had authorized a 5-for-4 forward stock split of the Company&#146;s Common Stock to be effected in the form of a stock dividend of one share of the Company&#146;s Common Stock for every four shares of Common Stock outstanding on the record date.&#160; The record date for the forward stock split is May&nbsp;2, 2011, and the payment date is May&nbsp;5, 2011.&#160;&#160; The Board of Directors also made corresponding adjustments to the number of shares subject to the Company&#146;s stock incentive plans and to the number of shares subject to, and the exercise price of, outstanding options and other rights to acquire Common Stock.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information in this Current Report on Form&nbsp;8-K (including the exhibit attached hereto) is furnished pursuant to General Instruction shall not be deemed to be &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Merit under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Item 9.01.&#160;&#160;&#160; <u>Financial Statements and Exhibits</u></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1 &#160;&#160;&#160;&#160;&#160;&#160;&#160; Press Release dated April&nbsp;21, 2011 entitled &#147;Merit Medical Announces 5-for-4 Forward Stock Split.&#148;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_213536_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C900817\11-10719-1\task4630157\10719-1-ba.htm',USER='C900817',CD='Apr 21 21:37 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MERIT MEDICAL SYSTEMS,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   April&nbsp;21, 2011</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="46%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Kent W. Stanger</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="46%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:46.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Financial Officer, Secretary and Treasurer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_213649_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\C900817\11-10719-1\task4630157\10719-1-ba.htm',USER='C900817',CD='Apr 21 21:37 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">EXHIBIT&nbsp;<br>   NUMBER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="89%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:89.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">DESCRIPTION</font></b></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="89%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:89.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="89%" valign="top" style="padding:0in 0in 0in 0in;width:89.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   Release, dated April&nbsp;21, 2011, entitled &#147;Merit Medical Announces 5-for-4   Forward Stock Split.&#148;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_213741_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\C900817\11-10719-1\task4630157\10719-1-ba.htm',USER='C900817',CD='Apr 21 21:37 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-10719_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="334" height="53" src="g107191mmi001.jpg"></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1600 West Merit Parkway </font><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> South Jordan, UT 84095</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telephone:&#160; 801-253-1600 </font><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="2" style="font-size:10.0pt;"> Fax:&#160; 801-253-1688</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PRESS</font></b><font size="2" style="font-size:10.0pt;">RELEASE</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;21,   2011</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contact:</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anne-Marie   Wright, Vice President, Corporate Communications</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phone:</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(801)   208-4167 e-mail: awright@merit.com Fax: (801) 253-1688</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">MERIT MEDICAL ANNOUNCES</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">5-FOR-4 FORWARD STOCK SPLIT</font></u></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SOUTH JORDAN, UTAH&#151; Merit Medical Systems,&nbsp;Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that its Board of Directors has approved a five-for-four forward stock split of the Company&#146;s Common Stock, to be effected in the form of a stock dividend of one share of the Company&#146;s Common Stock for every four shares outstanding.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The record date for the stock split is May&nbsp;2, 2011.&#160; Stockholders of record will receive one new share of Common Stock for every four shares they own.&#160; The distribution of the stock dividend will be made on May&nbsp;5, 2011, and trading of Merit Medical shares on a split-adjusted basis will begin on May&nbsp;6, 2011.&#160; Giving effect to the stock split, the number of outstanding shares of Merit Medical stock will increase to approximately 36.2 million shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ABOUT MERIT</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Founded in 1987, Merit Medical Systems,&nbsp;Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy.&#160; Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 130 individuals.&#160; Merit employs approximately 2,200 people worldwide with facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106319\11-10719-1\task4630253\10719-1-mm.htm',USER='106319',CD='Apr 21 22:04 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Richmond, Virginia; Maastricht and Venlo, The Netherlands; Paris, France; Galway,&nbsp;Ireland; Beijing, China; Copenhagen, Denmark; and Rockland, Massachusetts.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Statements contained in this release which are not purely historical, including, without limitation, statements regarding Merit&#146;s forecasted revenues, net income and other financial results, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties such as those described in Merit&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010. Such risks and uncertainties include risks relating to product recalls and product liability claims; potential restrictions on Merit&#146;s liquidity or its ability to operate its business by its current debt agreements; possible infringement of Merit&#146;s technology or the assertion that Merit&#146;s technology infringes the rights of other parties; the potential of fines, penalties, or other adverse consequences if Merit&#146;s employees or agents violate the U.S. Foreign Corrupt Practices Act or other laws and regulations; expenditures relating to research, development, testing and regulatory approval or clearance of Merit&#146;s products and the risk that such products may not be developed successfully or approved for commercial use; greater governmental scrutiny and regulation of the medical device industry; reforms to the 510(k)&nbsp;process administered by the U.S. Food and Drug Administration; laws targeting fraud and abuse in the healthcare industry; potential for significant adverse changes in, or failure to comply with, governing regulations; increases in the price of commodity components; negative changes in economic and industry conditions in the United States and other countries; termination or interruption of relationships with Merit&#146;s suppliers, or failure of such suppliers to perform; Merit&#146;s potential inability to successfully manage growth through acquisitions, including the inability to commercialize technology acquired through recent, proposed or future acquisitions, including the Biosphere acquisition; fluctuations in Euro and GBP exchange rates; Merit&#146;s need to generate sufficient cash flow to fund its debt obligations, capital expenditures, and ongoing operations; concentration of Merit&#146;s revenues among a few products and procedures; development of new products and technology that could render Merit&#146;s existing products obsolete; market acceptance of new products; volatility in the market price of Merit&#146;s common stock; modification or limitation of governmental or private insurance reimbursement policies; changes in health care markets related to health care reform initiatives; failure to comply with applicable environmental laws; changes in key personnel; work stoppage&nbsp;or transportation risks; uncertainties associated with potential healthcare policy changes which may have a material adverse effect on Merit; introduction of products in a timely fashion; price and product competition; availability of labor and materials; cost increases; fluctuations in and obsolescence of inventory; and other factors referred to in Merit&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010 and other materials filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106319\11-10719-1\task4630253\10719-1-mm.htm',USER='106319',CD='Apr 21 22:04 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g107191mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g107191mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MP``+"``U`4X!`1$`_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+
M_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ_]H`"`$!```_`.D\=_%7_A"M=CTO^Q?MN^W6;S/M7EXR6&,;#_=]>]<W
M_P`-"?\`4K?^3_\`]KH_X:$_ZE;_`,G_`/[71_PT)_U*W_D__P#:Z/\`AH3_
M`*E;_P`G_P#[71_PT)_U*W_D_P#_`&NC_AH3_J5O_)__`.UUV?P]^(7_``GG
M]H?\2O[!]B\K_EX\W?OW?[*XQL_6NSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHKY[^.W_(]P?\`8/C_`/0WKS>NB\,:+:7%K>:UJR!["S`2.%IQ#]IG;[L>
MX]!@%C@YP/>N[\&>`_#WC9A?OIJZ;%9RE+BVMKTSI.",K\VXE2.<C/I6GXU^
M&O@[P_:QZTD#0P0`J;$W9473G[J[W)*]\X/0<<UE>#/`GA[QM(+Y].&FQ64F
MVXM;:],\<X(RN&R2IZY&?3I4/Q=^'VB>&-*L]5T6%K5))_L\L)D9P259@P+$
MD?=/?N*T?V>_^9@_[=O_`&K7LU(2`"2<`=2:^;_'_P`1]5USQ%<)IFIW%MID
M#[($@D*;\=7)4\Y.2/;%>D?"_P`8W$_P\O=3U^[:5-+E=#._+M&$5@"?XCR1
MZGBO'M<\=^(M<U2:]DU2[@5V)C@AG94C7LH`QT]>IK._X2+7/^@SJ'_@4_\`
MC6[X+\9>(;'Q7IVS5+NX2>XCAEAFF9UD5F`(P3UYX-6OB'XTUV]\9ZG!'J=U
M;6UG<O;Q0PRE%`0E2>,9)()R?6N8_P"$BUS_`*#.H?\`@4_^-7M*\=^*-&NT
MN+76KMMIYCFE:2-AGH58D?UKVRX^(YO_`(3WOBC3HUBO8%6&2(G/DRLRIGW'
MS!A7@\GB;7Y9&DDUO4&9CDDW3\_K3?\`A(M<_P"@SJ'_`(%/_C1_PD6N?]!G
M4/\`P*?_`!I\/BCQ!;S)-%K>H*Z'*G[2YY_.OHN+Q9<P?#>RUZXA\W4+JVB6
M*$#'G3OA4`]`20?I5:3P5<P:*]])K^IG7HXS,UY]I;R_,`SM\K.S9GC&.E%W
MXBO]=T?0-.TV0VFHZ[;I<3RQ<FT@V@R./?)"K[GVJ^OP_P!&VCS+C5I7[N^J
M7&6]SAQ2GX?Z&1CS-4'O_:EQ_P#%US=[J&L:'JDWA"VU>><7EQ:I:WDQWS6L
M<OF;U+?Q$"(E2>?F&?6NA_X5YHYC"M=ZN[C[TC:G/N8^I^;'Z4'P+'"0^G>(
M==LI%&`1?-*I^JR;@:@;6]<\)2QIXE,>H:4Y"_VM!'Y;0$G`\Z,<`'^^O`[B
MB\BN?%'C"\TM]3NK33=,MX)&CLY3$UP\N\@LXYV@+T&.:DT6XF\.ZQJNCZAJ
MDESI]I:1WT%Q=OEX8V+JR,_\0!C)!/.#4<-WXA\8?O\`3YWT'1B?W<YB#75T
MO]Y0W$:GMD$GT%3CP':%/WFN^())>\QU24-GZ`@#\JK7$FN>"V@N+G57UC16
MFCAF-T@%S;[V"*P=0`ZY(R",\]:N:YJ>IWVMIX;T*=;:?RA/>WK+N^S1$X4*
M#P7;!QGH!FF#P)$L89/$.OK=#G[2=1=B3ZE3\F/;&*G\-:GJ)OK[0-:=9K[3
MPCI=*@074+YVOM'0Y4@CID5E6M]J/_"0*INW:9K@*\!E8LO,>\>5T"!6?#_[
M(/4Y/;U\]_';_D>X/^P?'_Z&]>=VMM->74-K;QF2:=UCC0=68G`'YFO2=9T.
MZM8;/PY9V&KM!IXVR/'HBSQSW#??D#.PXZ*..B]:]E\)^'H?#/A^#3HQ&9!\
M\\B1+'YDAZDA>/0?0"O-_B5<ZAXAUY;"WL=8-I9G8NS11/')(>KAG8<=LX['
MGFO1_"/AR'PQX?@T]-C2_?GD6)8_,<]20O''`[\`<FN-^/7_`"(]G_V$D_\`
M1<M8W[/?_,P?]NW_`+5KV:O/_C!XL_X1[PL;"VD*WVIYB0J>4C_C;\CC\?:O
MG.MJ/Q)-!X*D\-P@JEQ>FYG;^^`JA5_,$GZ"L6N_\,7'PPC\/6R^(K*\DU0;
M_/:,R;3\YVXPP'W=M=_X`B^&%YKGF^'+4IJ4*EHUN3(6`[LH8D9^G(KQKQG_
M`,CQKW_82N/_`$8U=SX6T3X?6_@"SUOQ9&PGN)I(U*RR[GVMCA5/88YKB_&3
M>&&UL'PFLZV'DKN$V[_69.<;N<8V]>^:U_#0N/\`A57C,G=]G+66W)XW^=SC
M\,9_"N9T"UAOO$>F6=PN^&XNXHI%R1E6<`C(]C7KWQ'^''A;P]X(O=3TS3WA
MNHFC".9Y&QEU!X)(Z$UY)X:LX-1\4Z38W2;X+F]ABE4$C<K.`1D<C@U]#1?"
M+P1#,DHT<L48,`]Q(RG'J"V"/:IX(4\0>,U>-5_LOP[F*)5&%>[(P2.V(T./
MJQ]*Z34/^0;=?]<7_D:X[X6:%<V?AV#5M3R;Z\MXHT#?\LK=!B-0.V?O'W:N
MC\5-JJ^&;\Z'N_M$1_Z/L`)W9'KQ^=<4T_BQ5+,_C#:!D[;:P)Q[`'FA+;1Q
M:^'=0TNYN;R6]\0QM=7-X<SO(L4JE7&!MVXQMP`.U=5X\O;O3_"%U<6-R]M<
M>;`BRH!N4-,BG&01T)JM-H_BO2D-QI?B%M4*<FSU*%,2#N%D0*5/ID$5KZ9?
MV7BGP^LY@W6]TC1SV\PY4\J\;#U!R#7&?#.VNK#Q7XKTRZE,OV`VMO"YZF$>
M:8\GUVD"I?$6F2ZY\3X=*8C[#)86\U\A_P"6D4<LY"'V+E,^U=5XAUS^PK.!
M+>V-U>W<HM[.U4X\QR">3_"H`))[`5F+H_C>5!<2>++6&XZ_9HM.5K<>V2=Y
M^N1]*SM>'B&XTQI/%`TVQT:Q9;F[:UE>22Y\M@RHH*C:"P'J>@K;\&Z;<VNE
M2:AJ*;=2U64W=T/[A(^6/Z*H5?P-1>'O%R^(/%&N:9!&GV72S&B3#.9&.X/[
M8!7`^AIK_+\5H=O'F:')O]]LZ;?RW-^==117SW\=O^1[@_[!\?\`Z&]9O@>T
M32[&Y\37$]G!/\UOIOVR1D1I"/G?@9^53QCNWM7<?"SP;:2ZD=>EMM*DBM3M
MMI+&6=_WN.<[V(X!].I'I7=^-_$2>']!D9+NTM[RY!CM_M<A1,]SE>>!Z=\5
MP?PO\&VUSJQU^>WTF6*U8^1)92SR9E[DEV(X!].I'3%>M-=0+=I:&51/)&TB
MQYY*J5!/T!9?SKS?X]?\B/9_]A)/_1<M8W[/?_,P?]NW_M6O8Y)$AB>61@B(
MI9F)X`'4U\K^.O%$GBWQ3=:CN;[,#Y=JA_AC'3\^6/N:YX@J<$$=^:*5E9&*
ML"K`X((P0:TK/PSK^H6J75EH>HW5O)G9+#:2.C8.#@@8/((_"NZ^%?@;Q%'X
MSM-4O=-NM/M;(NSO<QF,N2I`4`X)SNZ],`UQ?C/_`)'C7O\`L)7'_HQJV=5T
M:YG^%6@ZS'EH+:>XAE']W<^5/TXQ^5<E:PK<W<,#31P++(J&60X5`3C<?8=:
M]U\5>%+3P?\`!#4M,MG\YR89)YR,&5S-'D^PZ`#T%>->%/\`D;]%_P"PA!_Z
M,6OH#XQ?\DTU+_?A_P#1JUX'X,_Y'C0?^PE;_P#HQ:^F/%FLRZ+H;R6BB2_N
M76VLHS_',YPOX#EC[*:?I5C:>$O#"Q33CR[2)I;FX?\`C;EG<_4Y-:%K,E_I
MT,Y3"7$2N4//##./UJOJNKVFBPVIN"%^U745I"@X+.[!0!]!D_0&IM2U*TT?
M3I]0OYO)MK==TDFTMM'T`)-8)^(WAC'RW5XQ[`:;<Y/_`)#KEY;>_:;3=6>T
M^Q?VKXLAN(;>8%66(0,FYAV=@I./<9KI?B9YO_""7OD;/-\ZVV;\[=WVB/&<
M=LUU73DUR_@,F:RU>\3'V6[U>YEM<=#'D*2/JRN?QJGX597^)OC@H01FQ''J
M(F!_6K*?\E>F/FX']@QCR]H^8^>_.>V,'COGVJ#Q#%<V_P`2_#&H37P33V2>
MV6%HQ@3,A(^;L6&,?[F/XC79UR.LM_PD?C"T\/H=UEIFR^U''1GS^YB/X@N?
M916EXQU"_P!-\,7<VEVMQ<7K@10B")I&0L<;]J@G"C)_"N<^'=BUKKNK-#9:
MA;V"VEI#;F^LVMV)4/OZ_>)8EB?]O%:\G_)5K;_L!S?^CXZZBBO!/C)8R:G\
M3M-T^$@275M!"A;H"TC@?SK7>RN6OK70].TWQ-:6=J1:PL-&B,/7YI2\G9CE
MB>.O2O6M,L(],TZ"SC.X1(%+[0I<]V(``R3SQ7FGB.]U+7_$_DQ:?XGMH5D%
MO&PT:-H1\V"^]^=IZYXXQ7I.F6,>DZ7#:*QD$*`,^P`N>[848R3S@"N5\-:K
M>:SXVO+J:PURT@^RLL27^G"&%0&3[KGYBQY.#[^E3?$R":?PY;I!;W,["[4E
M;?2(]18#8_/ER$`#_:ZCIWK/^%EM<V_]J?:+2\M]WD[?M.@0Z;N^_P!/+)\S
M\>G'K53XV>*'TCPW'H]LQ6?5-RNP_AB7&X?CD#Z9KQ3POH%QXG\16FD6^09W
M^=\9\M!RS?@,_CBM7XH65OIWQ`U"RM(Q'!;QV\<:#LH@C`J;X8>$_P#A*O%D
M2W$0>PL\37.1D,!]U#]3^@-8?BH8\7ZR!_S_`,__`*,:ND\.?%S7_#&A6VC6
M5GITEO;;MC31R%SN8L<D.!U8]JT_^%]>*O\`H'Z1_P!^9?\`XY7GFIW\NJZK
M=ZC.J++=SO/(J`A0S,6(&<\9->]?#/2;;7?@^-+NUS#=&=&]1\YP1[@X/X5X
M3K.E7.AZQ=:7>+MGM9#&V.AQT(]B,$?6M^^^)6OZEX0_X1B[^S26GEI&92C>
M:0C!ERV['\('2LCPI_R-^B_]A"#_`-&+7T!\8O\`DFFI?[\/_HU:\#\&?\CQ
MH/\`V$K?_P!&+7T19J?$/CJZOI`39Z`3:VZGHURR@R/CV5E4?5JROBC=3ZEI
MUSX>LY&01V$VH7\B'[L4:DQI_P`#<#CT4UV6B?\`(!T__KUB_P#017GGBF:7
MQ#XIT[48YG&FZ/K=I:0!3\L\YE7S6/J%X4>^ZN]\2Z-_PD/AV]TC[1]G^UQ[
M/-V;]O(.<9&>GK67_8OC/_H<;3_P3C_XY43>%O$%[J&G3ZKXF@NX+"[6Z6&/
M31$68*R_>\PXX8]J=\3IDMO`5]/)G9%-;.V/07$9-5+*UU_QOIL5]?ZF=+TB
M^02)8V:8FDB/*[Y2>-PY(4#@]:Z#4]0TWPEX>,WE+%;6L8C@MXARYQA8T'<G
MH!7*?#K3KO3O%7B;^T'+7MVEI=7`SD(\GG,4'LN<?A2^)([^'X@R:MIL;33Z
M;IMO*]NO6>(R3K(H_P!K!R/=17521Z/XR\/+DI>6%VH961L$'J"".58'\016
M7_PC/B:)?L\'C:Y%KT!FL8I)P/3S.!^)4FM+3=,TOPEI$S&<K&"9KJ\NI,O*
MW=W8]3_D55_X6!X0_P"ACT__`+_"M#2?$.C:ZTJZ5J5O>&$`R"%PVW.<9_(U
MG:UX<U.]\00:SI6M1Z=/%:-:L)+,3AE9PW]Y<<J*B.C>-0I*^+[-F'0-I``/
MX^95[PMK-SK&G3"_A2&_L;E[2[6+.SS%P<KGL596]LX[5XS\;KB6T^(EG<P.
M8Y8;*)XW'56$CD'\ZYV7QR4>:]TW1K33M7N<^?J$+N6.?O%$)*H6[D>IQBMW
M4_C=XCO]%%E!#!9W+`"2[BSN/^Z#PN?Q]L5@R^-]DTFH:;H]MI^L7&?.OX7<
MGG[Q1"=J%NYYZG&,UT-]\<O$-WI<=K'9V<,^5\Z;:6$H'4;3P`>AZ\$XQ61I
MGQ&;P]>+<^'=!LM-+MNNAO>7SQS\OS'Y%YS@=P.>,5%XX^(VI^-T@@N((K2T
M@;>L,9)W/C&XD]>"<?4UW'[/?_,P?]NW_M6NU^(7P_@\<V=OBZ^R7EH6\J4K
MN4AL94C\!SVJO\._AM!X(^T74]TMY?W"A#(J;5C3.<+WY.,_05G_`!"^$[>+
M]835K"_CM+AD6.9)4)5\=&!'(../P'2NC\"^"[;P3HALHI?M%Q,_F7$^W;O.
M,``=@.WX^M<3XJ^",FK^(+K4M+U2*WBNY#*\4R,=KDY;!'8G)]JQ_P#A0&K_
M`/0;LO\`OV]'_"@-7_Z#=E_W[>@?`#5=PW:Y9@9Y(C8UZ]X9\/VOA?0+;2+1
MF>.`'+MU=B<D_F:Y+XB?"Q?&-_%J=C=QV=ZJ>7+YB$K*!T)QT(Z=.GTK@O\`
MA0OBK_H(:1_W^E_^-UT'@_X)76E:Y:ZGK>H6TJVD@E2"UW$,RG*Y8@<9YQBO
M3/$N@VWB?P_=Z/=LR1W*@;UZHP(*G\"!7G?A'X*MH7B.WU74M3BNH[1Q)#%%
M&1N<?=+$],'G`[UUTVD>(='UJ^O?#QL+FUU%Q--:WCM&8YMH4NK*#D$*,@CK
MWJSH?AJ2VMM1EUJ:*]U#5C_ICQIM0+MVB-`>=@&<9]2>]9=II/C?2]+70;&Y
MTIK2%1!;:A*7$T4(``S&!AG`X!W`=*TYO!UF?!\7AZVGD@^SA'AN0`7696W"
M4]B2W)]<FH(I_'T,8CEL-"N67CSA=RQ[_?;L./IFG_:_'7_0'T3_`,#Y?_C5
M'VOQU_T!]$_\#Y?_`(U52^T+Q'XJ\JR\1#3K325D62>VM)'E>YVG(4LRJ%7(
M!X!)QVI-/TWQKH5@FCZ>^D7EI;@1VMW=O(DB1CA0Z*,,0.,@C/'2K^F>%)%U
M)-7U[4'U;48\^22GEP6V?^><>2`>VXY/TINJ:/K%KK[Z[X?DM'EN84AO+2[+
M*DH0G8RNH)5AN(Z$$>E3:!H^I0:C>ZSK=Q!)?WB)$(K8'RK>)-Q503RQRQ)/
M'L!4%UX1DMM0EU+PWJ)TBYG;?/!Y8DMKAO[S1Y&&_P!I2#]:03^/47RVL=`E
M;IYHNID4^^W82/ID_6F1^%-0U:YCN?%FI1WZ1$,FGVT1CM0W8L"2TA';<<>U
M=-]GA_YXQ_\`?(KG]7T/4H=837/#LEK'>&(07-M<Y6*XC!)'*@E6&3@X/7!I
MOVOQU_T!]$_\#Y?_`(U2-<^/'4JFF:%$QX#M>RL%]\>6,_G6CX<T0Z'ITD4U
MP;J[N9WN;J<C'F2MU('8```#T`K.\1?#WP[XIU%=0U:VEEG6,1!DF9!M!)'`
M^IK*_P"%,>"O^?&?_P`"7_QH_P"%,>"O^?&?_P`"7_QH_P"%,>"O^?&?_P`"
M7_QH_P"%,>"O^?&?_P`"7_QH_P"%,>"O^?&?_P`"7_QH_P"%,>"O^?&?_P`"
M7_QK>\,^#-$\(_:?['@DB^U;/-WRL^=N<=>GWC6]11111111111111111111
-11111111111117__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
